ID   TBB5_HUMAN              Reviewed;         444 AA.
AC   P07437; P05218; Q8WUC1; Q9CY33;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   26-FEB-2020, entry version 230.
DE   RecName: Full=Tubulin beta chain;
DE   AltName: Full=Tubulin beta-5 chain;
GN   Name=TUBB; Synonyms=TUBB5; ORFNames=OK/SW-cl.56;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6688039; DOI=10.1016/0092-8674(83)90429-4;
RA   Lee M.G.-S., Lewis S.A., Wilde C.D., Cowan N.J.;
RT   "Evolutionary history of a multigene family: an expressed human beta-
RT   tubulin gene and three processed pseudogenes.";
RL   Cell 33:477-487(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6865944; DOI=10.1128/mcb.3.5.854;
RA   Hall J.L., Dudley L., Dobner P.R., Lewis S.A., Cowan N.J.;
RT   "Identification of two human beta-tubulin isotypes.";
RL   Mol. Cell. Biol. 3:854-862(1983).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=11504633; DOI=10.1016/s0968-0896(01)00103-1;
RA   Crabtree D.V., Ojima I., Geng X., Adler A.J.;
RT   "Tubulins in the primate retina: evidence that xanthophylls may be
RT   endogenous ligands for the paclitaxel-binding site.";
RL   Bioorg. Med. Chem. 9:1967-1976(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina T., Ota M., Katsuyama Y., Hashimoto N., Inoko H.;
RT   "Genome diversity in HLA: a new strategy for detection of genetic
RT   polymorphisms in expressed genes within the HLA class III and class I
RT   regions.";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-reactive
RT   CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Eye, Lung, Muscle, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-19; 47-77; 104-174; 242-276; 283-297; 310-359 AND
RP   363-390, METHYLATION AT ARG-318, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Foreskin fibroblast, and Mammary carcinoma;
RA   Bienvenut W.V., Campbell A., Ozanne B.W., Lourenco F., Olson M.F.;
RL   Submitted (DEC-2009) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 3-19; 47-58; 63-77; 104-121; 163-174; 242-251; 253-276;
RP   283-297; 310-318; 325-336 AND 381-390, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [12]
RP   PHOSPHORYLATION AT SER-172.
RX   PubMed=16371510; DOI=10.1091/mbc.e05-07-0621;
RA   Fourest-Lieuvin A., Peris L., Gache V., Garcia-Saez I., Juillan-Binard C.,
RA   Lantez V., Job D.;
RT   "Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-
RT   dependent kinase Cdk1.";
RL   Mol. Biol. Cell 17:1041-1050(2006).
RN   [13]
RP   GLYCYLATION.
RX   PubMed=19524510; DOI=10.1016/j.cell.2009.05.020;
RA   Rogowski K., Juge F., van Dijk J., Wloga D., Strub J.-M., Levilliers N.,
RA   Thomas D., Bre M.-H., Van Dorsselaer A., Gaertig J., Janke C.;
RT   "Evolutionary divergence of enzymatic mechanisms for posttranslational
RT   polyglycylation.";
RL   Cell 137:1076-1087(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-58, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=20191564; DOI=10.1002/cm.20436;
RA   Leandro-Garcia L.J., Leskela S., Landa I., Montero-Conde C.,
RA   Lopez-Jimenez E., Leton R., Cascon A., Robledo M., Rodriguez-Antona C.;
RT   "Tumoral and tissue-specific expression of the major human beta-tubulin
RT   isotypes.";
RL   Cytoskeleton 67:214-223(2010).
RN   [16]
RP   INTERACTION WITH PIFO.
RX   PubMed=20643351; DOI=10.1016/j.devcel.2010.06.005;
RA   Kinzel D., Boldt K., Davis E.E., Burtscher I., Trumbach D., Diplas B.,
RA   Attie-Bitach T., Wurst W., Katsanis N., Ueffing M., Lickert H.;
RT   "Pitchfork regulates primary cilia disassembly and left-right asymmetry.";
RL   Dev. Cell 19:66-77(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-55; THR-285 AND THR-290, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   INTERACTION WITH DIAPH1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23325789; DOI=10.1091/mbc.e12-08-0597;
RA   Li D., Dammer E.B., Lucki N.C., Sewer M.B.;
RT   "cAMP-stimulated phosphorylation of diaphanous 1 regulates protein
RT   stability and interaction with binding partners in adrenocortical cells.";
RL   Mol. Biol. Cell 24:848-857(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   GLUTAMYLATION.
RX   PubMed=26875866; DOI=10.1016/j.cell.2016.01.019;
RA   Valenstein M.L., Roll-Mecak A.;
RT   "Graded control of microtubule severing by tubulin glutamylation.";
RL   Cell 164:911-921(2016).
RN   [23]
RP   VARIANTS CDCBM6 VAL-299; ILE-353 AND LYS-401, AND CHARACTERIZATION OF
RP   VARIANTS CDCBM6 VAL-299 AND LYS-401.
RX   PubMed=23246003; DOI=10.1016/j.celrep.2012.11.017;
RA   Breuss M., Heng J.I., Poirier K., Tian G., Jaglin X.H., Qu Z., Braun A.,
RA   Gstrein T., Ngo L., Haas M., Bahi-Buisson N., Moutard M.L., Passemard S.,
RA   Verloes A., Gressens P., Xie Y., Robson K.J., Rani D.S., Thangaraj K.,
RA   Clausen T., Chelly J., Cowan N.J., Keays D.A.;
RT   "Mutations in the beta-tubulin gene TUBB5 cause microcephaly with
RT   structural brain abnormalities.";
RL   Cell Rep. 2:1554-1562(2012).
RN   [24]
RP   INVOLVEMENT IN CSCSC1, VARIANTS CSCSC1 LYS-15 AND PHE-222, CHARACTERIZATION
RP   OF VARIANTS CSCSC1 LYS-15 AND PHE-222, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=26637975; DOI=10.1016/j.ajhg.2015.10.014;
RA   Isrie M., Breuss M., Tian G., Hansen A.H., Cristofoli F., Morandell J.,
RA   Kupchinsky Z.A., Sifrim A., Rodriguez-Rodriguez C.M., Dapena E.P.,
RA   Doonanco K., Leonard N., Tinsa F., Moortgat S., Ulucan H., Koparir E.,
RA   Karaca E., Katsanis N., Marton V., Vermeesch J.R., Davis E.E., Cowan N.J.,
RA   Keays D.A., Van Esch H.;
RT   "Mutations in Either TUBB or MAPRE2 Cause Circumferential Skin Creases
RT   Kunze Type.";
RL   Am. J. Hum. Genet. 97:790-800(2015).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It binds
CC       two moles of GTP, one at an exchangeable site on the beta chain and one
CC       at a non-exchangeable site on the alpha chain.
CC   -!- SUBUNIT: Heterodimer of alpha and beta chains (PubMed:26637975). A
CC       typical microtubule is a hollow water-filled tube with an outer
CC       diameter of 25 nm and an inner diameter of 15 nM. Alpha-beta
CC       heterodimers associate head-to-tail to form protofilaments running
CC       lengthwise along the microtubule wall with the beta-tubulin subunit
CC       facing the microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different protofilament
CC       numbers can be found in some organisms and specialized cells. Interacts
CC       with PIFO (PubMed:20643351). Interacts with DIAPH1 (PubMed:23325789).
CC       Interacts with MX1 (By similarity). May interact with RNABP10 (By
CC       similarity). Interacts with CFAP157 (By similarity).
CC       {ECO:0000250|UniProtKB:P69893, ECO:0000250|UniProtKB:P99024,
CC       ECO:0000269|PubMed:20643351, ECO:0000269|PubMed:23325789,
CC       ECO:0000269|PubMed:26637975}.
CC   -!- INTERACTION:
CC       Q8AZK7:EBNA-LP (xeno); NbExp=3; IntAct=EBI-350864, EBI-1185167;
CC       P05412:JUN; NbExp=3; IntAct=EBI-350864, EBI-852823;
CC       Q5S007:LRRK2; NbExp=6; IntAct=EBI-350864, EBI-5323863;
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-350864, EBI-717399;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:26637975}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with highest levels in
CC       spleen, thymus and immature brain. {ECO:0000269|PubMed:20191564}.
CC   -!- DOMAIN: The highly acidic C-terminal region may bind cations such as
CC       calcium.
CC   -!- PTM: Some glutamate residues at the C-terminus are polyglutamylated,
CC       resulting in polyglutamate chains on the gamma-carboxyl group
CC       (PubMed:26875866). Polyglutamylation plays a key role in microtubule
CC       severing by spastin (SPAST). SPAST preferentially recognizes and acts
CC       on microtubules decorated with short polyglutamate tails: severing
CC       activity by SPAST increases as the number of glutamates per tubulin
CC       rises from one to eight, but decreases beyond this glutamylation
CC       threshold (PubMed:26875866). {ECO:0000269|PubMed:26875866}.
CC   -!- PTM: Some glutamate residues at the C-terminus are monoglycylated but
CC       not polyglycylated due to the absence of functional TTLL10 in human.
CC       Monoglycylation is mainly limited to tubulin incorporated into axonemes
CC       (cilia and flagella). Both polyglutamylation and monoglycylation can
CC       coexist on the same protein on adjacent residues, and lowering
CC       glycylation levels increases polyglutamylation, and reciprocally. The
CC       precise function of monoglycylation is still unclear (Probable).
CC       {ECO:0000305|PubMed:19524510}.
CC   -!- PTM: Phosphorylated on Ser-172 by CDK1 during the cell cycle, from
CC       metaphase to telophase, but not in interphase. This phosphorylation
CC       inhibits tubulin incorporation into microtubules.
CC       {ECO:0000269|PubMed:16371510}.
CC   -!- DISEASE: Cortical dysplasia, complex, with other brain malformations 6
CC       (CDCBM6) [MIM:615771]: A disorder of aberrant neuronal migration and
CC       disturbed axonal guidance. Affected individuals have microcephaly,
CC       ataxia, and severe delayed psychomotor development. Brain imaging shows
CC       variable malformations of cortical development, including white matter
CC       streaks, dysmorphic basal ganglia, corpus callosum abnormalities,
CC       brainstem and cerebellar hypoplasia, cortical dysplasia,
CC       polymicrogyria. {ECO:0000269|PubMed:23246003}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Skin creases, congenital symmetric circumferential, 1 (CSCSC1)
CC       [MIM:156610]: An autosomal dominant disease characterized by multiple,
CC       symmetric, circumferential rings of folded skin, affecting primarily
CC       the limbs. Affected individuals also exhibit intellectual disability,
CC       cleft palate, and dysmorphic features. {ECO:0000269|PubMed:26637975}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Tubulin entry;
CC       URL="https://en.wikipedia.org/wiki/Tubulin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J00314; AAB59507.1; -; Genomic_DNA.
DR   EMBL; AF141349; AAD33873.1; -; mRNA.
DR   EMBL; AF070561; AAC28642.1; -; mRNA.
DR   EMBL; AF070593; AAC28650.1; -; mRNA.
DR   EMBL; AF070600; AAC28654.1; -; mRNA.
DR   EMBL; BA000025; BAB63321.1; -; Genomic_DNA.
DR   EMBL; AB088100; BAC54932.1; -; Genomic_DNA.
DR   EMBL; AB062393; BAB93480.1; -; mRNA.
DR   EMBL; BC001938; AAH01938.1; -; mRNA.
DR   EMBL; BC002347; AAH02347.1; -; mRNA.
DR   EMBL; BC005838; AAH05838.1; -; mRNA.
DR   EMBL; BC007605; AAH07605.1; -; mRNA.
DR   EMBL; BC013374; AAH13374.1; -; mRNA.
DR   EMBL; BC019924; AAH19924.1; -; mRNA.
DR   EMBL; BC020946; AAH20946.1; -; mRNA.
DR   EMBL; BC021909; AAH21909.1; -; mRNA.
DR   EMBL; BC070326; AAH70326.1; -; mRNA.
DR   CCDS; CCDS4687.1; -.
DR   PIR; A26561; A26561.
DR   RefSeq; NP_001280141.1; NM_001293212.1.
DR   RefSeq; NP_001280142.1; NM_001293213.1.
DR   RefSeq; NP_001280143.1; NM_001293214.1.
DR   RefSeq; NP_001280144.1; NM_001293215.1.
DR   RefSeq; NP_001280145.1; NM_001293216.1.
DR   RefSeq; NP_821133.1; NM_178014.3.
DR   PDB; 3QNZ; X-ray; 2.20 A; C=429-438.
DR   PDB; 3QO0; X-ray; 2.30 A; C=422-441.
DR   PDB; 5N5N; EM; 4.00 A; A/B/C/D/E/F=1-426.
DR   PDB; 6I2I; EM; 3.60 A; B=1-444.
DR   PDB; 6QUS; EM; 3.70 A; S/U=1-444.
DR   PDB; 6QUY; EM; 3.80 A; G/H=1-444.
DR   PDB; 6QVJ; EM; 3.80 A; S/U=1-444.
DR   PDBsum; 3QNZ; -.
DR   PDBsum; 3QO0; -.
DR   PDBsum; 5N5N; -.
DR   PDBsum; 6I2I; -.
DR   PDBsum; 6QUS; -.
DR   PDBsum; 6QUY; -.
DR   PDBsum; 6QVJ; -.
DR   SMR; P07437; -.
DR   BioGrid; 128444; 349.
DR   CORUM; P07437; -.
DR   DIP; DIP-32772N; -.
DR   IntAct; P07437; 147.
DR   MINT; P07437; -.
DR   STRING; 9606.ENSP00000339001; -.
DR   ChEMBL; CHEMBL5444; -.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB05284; CA4P.
DR   DrugBank; DB01394; Colchicine.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB05147; CYT997.
DR   DrugBank; DB11731; Depatuxizumab mafodotin.
DR   DrugBank; DB01873; Epothilone D.
DR   DrugBank; DB12334; Milataxel.
DR   DrugBank; DB03010; Patupilone.
DR   DrugBank; DB01179; Podofilox.
DR   DrugBank; DB00570; Vinblastine.
DR   DrugBank; DB00541; Vincristine.
DR   DrugBank; DB11641; Vinflunine.
DR   DrugBank; DB00361; Vinorelbine.
DR   DrugBank; DB06042; ZEN-012.
DR   DrugCentral; P07437; -.
DR   GuidetoPHARMACOLOGY; 2640; -.
DR   iPTMnet; P07437; -.
DR   PhosphoSitePlus; P07437; -.
DR   SwissPalm; P07437; -.
DR   BioMuta; TUBB; -.
DR   DMDM; 56757569; -.
DR   OGP; P07437; -.
DR   REPRODUCTION-2DPAGE; P07437; -.
DR   SWISS-2DPAGE; P07437; -.
DR   UCD-2DPAGE; P07437; -.
DR   EPD; P07437; -.
DR   jPOST; P07437; -.
DR   MassIVE; P07437; -.
DR   PaxDb; P07437; -.
DR   PeptideAtlas; P07437; -.
DR   PRIDE; P07437; -.
DR   ProteomicsDB; 52002; -.
DR   TopDownProteomics; P07437; -.
DR   ABCD; P07437; -.
DR   Ensembl; ENST00000327892; ENSP00000339001; ENSG00000196230.
DR   Ensembl; ENST00000383564; ENSP00000373058; ENSG00000183311.
DR   Ensembl; ENST00000419792; ENSP00000401317; ENSG00000235067.
DR   Ensembl; ENST00000421473; ENSP00000399155; ENSG00000224156.
DR   Ensembl; ENST00000422650; ENSP00000400663; ENSG00000229684.
DR   Ensembl; ENST00000422674; ENSP00000406811; ENSG00000227739.
DR   Ensembl; ENST00000432462; ENSP00000410829; ENSG00000232421.
DR   Ensembl; ENST00000436628; ENSP00000410071; ENSG00000232575.
DR   GeneID; 203068; -.
DR   KEGG; hsa:203068; -.
DR   CTD; 203068; -.
DR   DisGeNET; 203068; -.
DR   GeneCards; TUBB; -.
DR   GeneReviews; TUBB; -.
DR   HGNC; HGNC:20778; TUBB.
DR   HPA; CAB005417; -.
DR   HPA; CAB012406; -.
DR   HPA; HPA043640; -.
DR   HPA; HPA046280; -.
DR   MalaCards; TUBB; -.
DR   MIM; 156610; phenotype.
DR   MIM; 191130; gene.
DR   MIM; 615771; phenotype.
DR   neXtProt; NX_P07437; -.
DR   OpenTargets; ENSG00000196230; -.
DR   Orphanet; 2505; Multiple benign circumferential skin creases on limbs.
DR   PharmGKB; PA358; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   GeneTree; ENSGT00940000154370; -.
DR   HOGENOM; CLU_015718_1_1_1; -.
DR   InParanoid; P07437; -.
DR   KO; K07375; -.
DR   OMA; ILLVCMF; -.
DR   OrthoDB; 962471at2759; -.
DR   PhylomeDB; P07437; -.
DR   TreeFam; TF300298; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; P07437; -.
DR   ChiTaRS; TUBB; human.
DR   GeneWiki; TUBB; -.
DR   GenomeRNAi; 203068; -.
DR   Pharos; P07437; Tclin.
DR   PRO; PR:P07437; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P07437; protein.
DR   Bgee; ENSG00000196230; Expressed in cerebral cortex and 233 other tissues.
DR   ExpressionAtlas; P07437; baseline and differential.
DR   Genevisible; P07437; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0044297; C:cell body; IDA:DFLAT.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0005641; C:nuclear envelope lumen; IDA:DFLAT.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IBA:GO_Central.
DR   GO; GO:0032794; F:GTPase activating protein binding; IEA:Ensembl.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0042288; F:MHC class I protein binding; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005198; F:structural molecule activity; TAS:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051301; P:cell division; TAS:BHF-UCL.
DR   GO; GO:0009987; P:cellular process; IDA:DFLAT.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; TAS:BHF-UCL.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0007017; P:microtubule-based process; IBA:GO_Central.
DR   GO; GO:0000278; P:mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; NAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0050807; P:regulation of synapse organization; IEA:Ensembl.
DR   GO; GO:0051225; P:spindle assembly; IEA:Ensembl.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR013838; Beta-tubulin_BS.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
DR   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; GTP-binding; Isopeptide bond;
KW   Methylation; Microtubule; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..444
FT                   /note="Tubulin beta chain"
FT                   /id="PRO_0000048243"
FT   NP_BIND         140..146
FT                   /note="GTP"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P99024"
FT   MOD_RES         55
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         58
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         58
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P99024"
FT   MOD_RES         172
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:16371510"
FT   MOD_RES         285
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         290
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         318
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000269|Ref.9"
FT   MOD_RES         438
FT                   /note="5-glutamyl polyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:Q2T9S0"
FT   CROSSLNK        58
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT   CROSSLNK        324
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT   VARIANT         15
FT                   /note="Q -> K (in CSCSC1; disrupts heterodimer assembly and
FT                   microtubule dynamics; dbSNP:rs864321676)"
FT                   /evidence="ECO:0000269|PubMed:26637975"
FT                   /id="VAR_076543"
FT   VARIANT         222
FT                   /note="Y -> F (in CSCSC1; disrupts heterodimer assembly and
FT                   microtubule dynamics; dbSNP:rs864321677)"
FT                   /evidence="ECO:0000269|PubMed:26637975"
FT                   /id="VAR_076544"
FT   VARIANT         299
FT                   /note="M -> V (in CDCBM6; decreases the ability of the
FT                   protein to assemble into tubulin heterodimers;
FT                   dbSNP:rs587777355)"
FT                   /evidence="ECO:0000269|PubMed:23246003"
FT                   /id="VAR_071763"
FT   VARIANT         353
FT                   /note="V -> I (in CDCBM6; does not affect the ability of
FT                   the mutant polypeptides to assemble into heterodimers and
FT                   incorporate into microtubules; dbSNP:rs587777356)"
FT                   /evidence="ECO:0000269|PubMed:23246003"
FT                   /id="VAR_071764"
FT   VARIANT         401
FT                   /note="E -> K (in CDCBM6; arrests the assembly pathway of
FT                   alpha/beta-tubulin; the mutant protein is unable to
FT                   coassemble into a tubulin heterodimer but is instead
FT                   distributed throughout the cytoplasm; dbSNP:rs587777357)"
FT                   /evidence="ECO:0000269|PubMed:23246003"
FT                   /id="VAR_071765"
FT   CONFLICT        216
FT                   /note="K -> R (in Ref. 1; no nucleotide entry and 2;
FT                   AAB59507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        231
FT                   /note="A -> G (in Ref. 1; no nucleotide entry and 2;
FT                   AAB59507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        234..235
FT                   /note="SG -> EC (in Ref. 1; no nucleotide entry and 2;
FT                   AAB59507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        288
FT                   /note="E -> D (in Ref. 1; no nucleotide entry and 2;
FT                   AAB59507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        298
FT                   /note="N -> D (in Ref. 8; AAH20946)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   444 AA;  49671 MW;  1E6CD0A36773A103 CRC64;
     MREIVHIQAG QCGNQIGAKF WEVISDEHGI DPTGTYHGDS DLQLDRISVY YNEATGGKYV
     PRAILVDLEP GTMDSVRSGP FGQIFRPDNF VFGQSGAGNN WAKGHYTEGA ELVDSVLDVV
     RKEAESCDCL QGFQLTHSLG GGTGSGMGTL LISKIREEYP DRIMNTFSVV PSPKVSDTVV
     EPYNATLSVH QLVENTDETY CIDNEALYDI CFRTLKLTTP TYGDLNHLVS ATMSGVTTCL
     RFPGQLNADL RKLAVNMVPF PRLHFFMPGF APLTSRGSQQ YRALTVPELT QQVFDAKNMM
     AACDPRHGRY LTVAAVFRGR MSMKEVDEQM LNVQNKNSSY FVEWIPNNVK TAVCDIPPRG
     LKMAVTFIGN STAIQELFKR ISEQFTAMFR RKAFLHWYTG EGMDEMEFTE AESNMNDLVS
     EYQQYQDATA EEEEDFGEEA EEEA
//
